References
Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68:394–424.
Cortazar P, Zhang L, Untch M, et al. Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis. Lancet. 2014;384:164–72.
Spring LM, Fell G, Arfe A, et al. Pathologic complete response after neoadjuvant chemotherapy and impact on breast cancer recurrence and survival: a comprehensive meta-analysis. Clin Cancer Res. 2020;26:2838–48.
Korn E, Sachs M, McShane L. Statistical controversies in clinical research: assessing pathologic complete response as a trial-level surrogate end point for early-stage breast cancer. Ann Oncol. 2016;27:10–5.
Wu G, Cheligeer C, Brisson AM, et al. A new method of identifying pathologic complete response following neoadjuvant chemotherapy for breast cancer patients using a population-based electronic medical record system. Ann Surg Oncol. 2022. https://doi.org/10.1245/s10434-022-12955-6
Acknowledgment
This project entitled “Building Pipeline to Transform Real-World Data to Evidence to Improve Cancer Care” was supported by the Canadian Cancer Society (CCS).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Disclosure
There are no conflicts of interest.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Wu, G., Cheligeer, C. & Xu, Y. ASO Author Reflections: Development of Natural Language Processing-Based Machine-Learning Algorithms to Identify Pathologic Complete Response from Surgical Pathology Reports. Ann Surg Oncol 30, 2104–2105 (2023). https://doi.org/10.1245/s10434-022-12967-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1245/s10434-022-12967-2